Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Diabetic kidney disease
Merlin C. Thomas, Michael Brownlee, Katalin Suszták, et al.
Nature Reviews Disease Primers (2015) Vol. 1, Iss. 1
Open Access | Times Cited: 909

Showing 1-25 of 909 citing articles:

Changing epidemiology of type 2 diabetes mellitus and associated chronic kidney disease
Merlin C. Thomas, Mark E. Cooper, Paul Zimmet
Nature Reviews Nephrology (2015) Vol. 12, Iss. 2, pp. 73-81
Closed Access | Times Cited: 580
The Global Epidemiology of Diabetes and Kidney Disease
Digsu N. Koye, Dianna J. Magliano, Robert G. Nelson, et al.
Advances in Chronic Kidney Disease (2018) Vol. 25, Iss. 2, pp. 121-132
Closed Access | Times Cited: 523
The tubular hypothesis of nephron filtration and diabetic kidney disease
Volker Vallon, Scott C. Thomson
Nature Reviews Nephrology (2020) Vol. 16, Iss. 6, pp. 317-336
Open Access | Times Cited: 323
Network biology concepts in complex disease comorbidities
Jessica Xin Hu, Cecilia Engel Thomas, Søren Brunak
Nature Reviews Genetics (2016) Vol. 17, Iss. 10, pp. 615-629
Closed Access | Times Cited: 304
Sodium-Glucose Co-transporters and Their Inhibition: Clinical Physiology
Ele Ferrannini
Cell Metabolism (2017) Vol. 26, Iss. 1, pp. 27-38
Open Access | Times Cited: 284
Diabetic vascular diseases: molecular mechanisms and therapeutic strategies
Yiwen Li, Yanfei Liu, Shiwei Liu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 250
Pathogenic Pathways and Therapeutic Approaches Targeting Inflammation in Diabetic Nephropathy
Sandra Rayego‐Mateos, José Luis Morgado‐Pascual, Lucas Opazo-Ríos, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 11, pp. 3798-3798
Open Access | Times Cited: 223
Clinical efficacies, underlying mechanisms and molecular targets of Chinese medicines for diabetic nephropathy treatment and management
Guoyi Tang, Sha Li, Cheng Zhang, et al.
Acta Pharmaceutica Sinica B (2021) Vol. 11, Iss. 9, pp. 2749-2767
Open Access | Times Cited: 210
Fast renal decline to end-stage renal disease: an unrecognized feature of nephropathy in diabetes
Andrzej S. Królewski, Jan Skupień, Peter Rossing, et al.
Kidney International (2017) Vol. 91, Iss. 6, pp. 1300-1311
Open Access | Times Cited: 185
Diabetic kidney diseases revisited: A new perspective for a new era
Haiyan Fu, Silvia Liu, Sheldon Bastacky, et al.
Molecular Metabolism (2019) Vol. 30, pp. 250-263
Open Access | Times Cited: 183
Molecular pathways that drive diabetic kidney disease
Samer Mohandes, Tomohito Doke, Hailong Hu, et al.
Journal of Clinical Investigation (2023) Vol. 133, Iss. 4
Open Access | Times Cited: 179
FXR/TGR5 Dual Agonist Prevents Progression of Nephropathy in Diabetes and Obesity
Xiaoxin X. Wang, Dong Wang, Yuhuan Luo, et al.
Journal of the American Society of Nephrology (2017) Vol. 29, Iss. 1, pp. 118-137
Open Access | Times Cited: 175
Artificial intelligence predicts the progression of diabetic kidney disease using big data machine learning
Masaki Makino, Ryo Yoshimoto, Masaki Ono, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 168
Chronic Diabetes Complications: The Need to Move beyond Classical Concepts
Dı́dac Mauricio, Núria Alonso, Mónica Gratacòs
Trends in Endocrinology and Metabolism (2020) Vol. 31, Iss. 4, pp. 287-295
Closed Access | Times Cited: 155
Diabetes mellitus: Classification, mediators, and complications; A gate to identify potential targets for the development of new effective treatments
Samar A. Antar, Nada A. Ashour, Marwa Sharaky, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 168, pp. 115734-115734
Open Access | Times Cited: 150
Signaling Pathways Involved in Diabetic Renal Fibrosis
Yuqing Zhang, De Jin, Xiaomin Kang, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 141
Diabetic Kidney Disease: Challenges, Advances, and Opportunities
Ya Chen, Kyung Lee, Zhaohui Ni, et al.
Kidney Diseases (2020) Vol. 6, Iss. 4, pp. 215-225
Open Access | Times Cited: 140
HMGB1 regulates ferroptosis through Nrf2 pathway in mesangial cells in response to high glucose
You Wu, Ying Zhao, Han-Ze Yang, et al.
Bioscience Reports (2021) Vol. 41, Iss. 2
Open Access | Times Cited: 136
Glomerular hyperfiltration
Monica Cortinovis, Norberto Perico, Piero Ruggenenti, et al.
Nature Reviews Nephrology (2022) Vol. 18, Iss. 7, pp. 435-451
Closed Access | Times Cited: 117
Pathophysiologic Mechanisms and Potential Biomarkers in Diabetic Kidney Disease
Chan‐Young Jung, Tae‐Hyun Yoo
Diabetes & Metabolism Journal (2022) Vol. 46, Iss. 2, pp. 181-197
Open Access | Times Cited: 117
The Epidemiology of Diabetic Kidney Disease
Ellen K. Hoogeveen
Kidney and Dialysis (2022) Vol. 2, Iss. 3, pp. 433-442
Open Access | Times Cited: 117
Mitochondrial dysfunction in diabetic tubulopathy
Lan Yao, Xianhui Liang, Yingjin Qiao, et al.
Metabolism (2022) Vol. 131, pp. 155195-155195
Open Access | Times Cited: 95
Inter-organ crosstalk during development and progression of type 2 diabetes mellitus
Georgia Xourafa, Melis Korbmacher, Michael Roden
Nature Reviews Endocrinology (2023) Vol. 20, Iss. 1, pp. 27-49
Open Access | Times Cited: 92
The cardio-renal-metabolic connection: a review of the evidence
Marella Marassi, Gian Paolo Fadini
Cardiovascular Diabetology (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 84
The Metabolic Syndrome, a Human Disease
M. Alemany
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 4, pp. 2251-2251
Open Access | Times Cited: 29
Page 1 - Next Page

Scroll to top